Literature DB >> 18674916

9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.

Yan Ma1, Tian-Miao Ou, Jin-Qiang Hou, Yu-Jing Lu, Jia-Heng Tan, Lian-Quan Gu, Zhi-Shu Huang.   

Abstract

A series of 9-N-substituted berberine derivatives (2a-j) were synthesized and evaluated as a new class of G-quadruplex binding ligands. G-quadruplex of DNA had been proven to be the transcription controller of human c-myc gene. The interaction of 9-N-substituted berberine derivatives with G-quadruplex DNA in c-myc was examined via EMSA, CD spectroscopy, FRET-melting method, PCR-stop assay, competitive dialysis, cell proliferation assay, and RT-PCR assay. The experiment results indicated that these derivatives could selectively induce and stabilize the formation of intramolecular parallel G-quadruplex in c-myc, which led to down-regulation of transcription of the c-myc in the HL60 lymphomas cell line. The related structure-activity relationships were also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674916     DOI: 10.1016/j.bmc.2008.07.029

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  28 in total

1.  Aminoglycoside binding to Oxytricha nova telomeric DNA.

Authors:  Nihar Ranjan; Katrine F Andreasen; Sunil Kumar; David Hyde-Volpe; Dev P Arya
Journal:  Biochemistry       Date:  2010-10-22       Impact factor: 3.162

2.  Berberine Molecular Recognition of the Parallel MYC G-Quadruplex in Solution.

Authors:  Jonathan Dickerhoff; Nicole Brundridge; Scott A McLuckey; Danzhou Yang
Journal:  J Med Chem       Date:  2021-10-22       Impact factor: 7.446

3.  Binding of plant alkaloids berberine and palmatine to serum albumins: a thermodynamic investigation.

Authors:  Asma Yasmeen Khan; Maidul Hossain; Gopinatha Suresh Kumar
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

4.  New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.

Authors:  Ming-Hao Hu; Tian-Ying Wu; Qiong Huang; Guangyi Jin
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

5.  Synthesis, characterization and biological evaluation of six highly cytotoxic ruthenium(ii) complexes with 4'-substituted-2,2':6',2''-terpyridine.

Authors:  Qi-Pin Qin; Ting Meng; Ming-Xiong Tan; Yan-Cheng Liu; Shu-Long Wang; Bi-Qun Zou; Hong Liang
Journal:  Medchemcomm       Date:  2018-02-02       Impact factor: 3.597

6.  Berberine enhances defects in the establishment of leaf polarity in asymmetric leaves1 and asymmetric leaves2 of Arabidopsis thaliana.

Authors:  Ayami Nakagawa; Hiro Takahashi; Shoko Kojima; Nobuo Sato; Kazuomi Ohga; Byung Yoon Cha; Je-Tae Woo; Kazuo Nagai; Gorou Horiguchi; Hirokazu Tsukaya; Yasunori Machida; Chiyoko Machida
Journal:  Plant Mol Biol       Date:  2012-06-10       Impact factor: 4.076

7.  Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes.

Authors:  Yuebin Ge; Yan Zhang; Rui Li; Wei Chen; Yang Li; Guoxun Chen
Journal:  Int J Biol Sci       Date:  2011-05-24       Impact factor: 6.580

8.  Biophysical characterization of the strong stabilization of the RNA triplex poly(U)•poly(A)*poly(U) by 9-O-(ω-amino) alkyl ether berberine analogs.

Authors:  Debipreeta Bhowmik; Suman Das; Maidul Hossain; Lucy Haq; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

9.  The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1.

Authors:  Carla Bazzicalupi; Marta Ferraroni; Anna Rita Bilia; Francesca Scheggi; Paola Gratteri
Journal:  Nucleic Acids Res       Date:  2012-10-26       Impact factor: 16.971

10.  Binding of the 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs to tRNA(phe.).

Authors:  Anirban Basu; Parasuraman Jaisankar; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.